Hepion Pharmaceuticals, Inc. (Nasdaq:HEPA)
Health Care/Life Sciences • Biotechnology
CIK 1583771
Company
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.
Address
399 Thornall Street
1st Floor
Edison, New Jersey 08837
399 Thornall Street
1st Floor
Edison, New Jersey 08837
Employees
25
25
Stock Info
Close
$2.6000
$2.6000
Day Range
2.5204 - 2.9252
2.5204 - 2.9252
52 Week Range
1.4900 - 20.6600
1.4900 - 20.6600
Average volume
89.83K
89.83K
Short Interest
79.08K (02/15/24)
79.08K (02/15/24)
% of Float Shorted
1.85%
1.85%
Market Cap
$12.28M
$12.28M
Revenue
N/A
N/A
Net Income
-$42.2M
-$42.2M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chairman John Patrick Brancaccio CPA |
Independent Director Timothy M Block PhD |
Independent Director Kaouthar Lbiati MD |
SEC filings
Date | Form | Event |
---|---|---|
5 Sep, 2024 | 425 | |
5 Sep, 2024 | 8-K | |
13 Aug, 2024 | 10-Q | |
7 Aug, 2024 | 8-K | |
7 Aug, 2024 | 425 | |
24 Jul, 2024 | D | |
22 Jul, 2024 | 425 | |
22 Jul, 2024 | 8-K | |
15 Jul, 2024 | 424B3 | |
15 Jul, 2024 | EFFECT | |
12 Jul, 2024 | CORRESP | |
12 Jul, 2024 | UPLOAD | |
11 Jul, 2024 | S-1 | |
25 Jun, 2024 | 10-K/A | |
21 May, 2024 | 10-Q | |
15 May, 2024 | NT 10-Q | |
16 Apr, 2024 | 10-K | |
1 Apr, 2024 | NT 10-K | |
7 Mar, 2024 | 4 | |
6 Mar, 2024 | 8-K | |
6 Mar, 2024 | 3 | |
21 Feb, 2024 | 4 | |
21 Feb, 2024 | 4 | |
21 Feb, 2024 | 4 | |
21 Feb, 2024 | 4 | |
20 Feb, 2024 | 8-K | |
16 Feb, 2024 | 8-K | |
14 Feb, 2024 | SC 13G | |
7 Feb, 2024 | 8-K | |
3 Jan, 2024 | 8-K | |
7 Dec, 2023 | 8-K | CEO Change |
28 Nov, 2023 | 4 | |
20 Nov, 2023 | 10-Q | |
14 Nov, 2023 | NT 10-Q | |
8 Nov, 2023 | EFFECT | |
6 Nov, 2023 | CORRESP | |
3 Nov, 2023 | UPLOAD | |
31 Oct, 2023 | S-1 | |
3 Oct, 2023 | D | |
3 Oct, 2023 | 8-K | |
2 Oct, 2023 | 424B5 | |
20 Sep, 2023 | 4 | |
19 Sep, 2023 | 4 | |
18 Sep, 2023 | 4 | |
6 Sep, 2023 | 8-K | |
14 Aug, 2023 | 10-Q | |
24 Jul, 2023 | 8-K | |
21 Jul, 2023 | 424B5 | |
21 Jul, 2023 | 8-K | |
22 Jun, 2023 | 8-K | |
22 May, 2023 | 8-K | |
12 May, 2023 | 10-Q | |
10 May, 2023 | 8-K | |
28 Apr, 2023 | DEFA14A | |
28 Apr, 2023 | ARS | |
28 Apr, 2023 | DEF 14A | |
10 Apr, 2023 | 10-K | |
3 Apr, 2023 | NT 10-K | |
16 Dec, 2022 | 8-K | |
21 Nov, 2022 | DEF 14A | |
15 Nov, 2022 | D | |
14 Nov, 2022 | 10-Q | |
9 Nov, 2022 | PRE 14A | |
9 Nov, 2022 | 8-K | |
17 Oct, 2022 | 8-K | |
15 Aug, 2022 | 10-Q | |
5 Aug, 2022 | 8-K | |
26 Jul, 2022 | DEFA14A | |
25 Jul, 2022 | DEFA14A | |
20 Jul, 2022 | 3 | |
5 Jul, 2022 | 3 | |
30 Jun, 2022 | DEFA14A | |
28 Jun, 2022 | 8-K | |
27 Jun, 2022 | 8-K | |
24 Jun, 2022 | DEFA14A | |
14 Jun, 2022 | DEFA14A | |
6 Jun, 2022 | 8-K | |
31 May, 2022 | DEFA14A | |
27 May, 2022 | 8-K | |
16 May, 2022 | 10-Q | |
29 Apr, 2022 | DEF 14A | |
20 Apr, 2022 | PRE 14A | |
8 Apr, 2022 | 10-K | |
31 Mar, 2022 | NT 10-K | |
14 Feb, 2022 | SC 13G/A | |
10 Feb, 2022 | SC 13G/A | |
19 Jan, 2022 | SC 13G/A | |
12 Jan, 2022 | 8-K | |
10 Jan, 2022 | 8-K | |
6 Jan, 2022 | 8-K | |
4 Jan, 2022 | SC 13G/A | |
21 Dec, 2021 | 8-K | |
30 Nov, 2021 | 8-K | |
24 Nov, 2021 | EFFECT | |
22 Nov, 2021 | CORRESP | |
19 Nov, 2021 | S-3/A | |
16 Nov, 2021 | 8-K | |
15 Nov, 2021 | 10-Q | |
10 Nov, 2021 | 8-K | |
8 Oct, 2021 | 8-K | |
7 Oct, 2021 | 8-K | |
30 Sep, 2021 | 8-K | |
29 Sep, 2021 | 8-K | |
13 Sep, 2021 | 8-K | |
7 Sep, 2021 | DEF 14A | |
23 Aug, 2021 | PRE 14A | |
23 Aug, 2021 | 8-K | |
16 Aug, 2021 | 10-Q | |
26 Jul, 2021 | 8-K | |
13 Jul, 2021 | 8-K | |
25 Jun, 2021 | DEFA14A | |
25 Jun, 2021 | 8-K | |
9 Jun, 2021 | 8-K | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
14 May, 2021 | 10-Q | |
12 May, 2021 | DEF 14A | |
6 May, 2021 | 8-K | |
29 Apr, 2021 | 8-K | |
28 Apr, 2021 | PRE 14A | |
28 Apr, 2021 | 10-K/A | |
7 Apr, 2021 | UPLOAD | |
2 Apr, 2021 | S-3 | |
31 Mar, 2021 | 10-K | |
23 Mar, 2021 | 8-K | |
11 Mar, 2021 | 8-K | |
24 Feb, 2021 | SC 13G | |
19 Feb, 2021 | SC 13G | |
18 Feb, 2021 | SC 13G | |
18 Feb, 2021 | 4 | |
18 Feb, 2021 | 4 | |
18 Feb, 2021 | 4 | |
17 Feb, 2021 | 8-K | |
16 Feb, 2021 | 424B5 | |
16 Feb, 2021 | SC 13G/A | |
16 Feb, 2021 | 424B5 | |
12 Feb, 2021 | FWP | |
10 Feb, 2021 | 8-K | |
10 Feb, 2021 | SC 13G | |
9 Feb, 2021 | SC 13G/A | |
28 Jan, 2021 | 8-K | |
20 Jan, 2021 | SC 13G/A | |
19 Jan, 2021 | S-8 | |
7 Jan, 2021 | SC 13G/A | |
5 Jan, 2021 | 8-K |
Last update:2024-03-06 12:08:54.386107
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.